GT Biopharma, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
GT Biopharma, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q1 2022 to Q1 2023.
  • GT Biopharma, Inc. Operating Lease, Liability, Noncurrent for the quarter ending March 31, 2023 was $31K, a 78.9% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $31K -$116K -78.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $64K Dec 31, 2022 10-K 2024-03-26
Q3 2022 $92K Sep 30, 2022 10-Q 2022-10-31
Q2 2022 $120K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $147K Mar 31, 2022 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.